Lower Extremity Artery Endovascular Intervention Outcomes in Patients with Autoimmune Rheumatic Disease: an Analysis of the US Nationwide Inpatient Sample 2012 – 2020
European Journal of Vascular and Endovascular Surgery · 2025
DOI: 10.1016/j.ejvs.2025.09.052 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025. Verfasst von Yi-Fan Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taitung, Taiwan; Department of …. Hauptthemen laut MEDLINE: Endovascular Procedures, Lower Extremity, Peripheral Arterial Disease, Autoimmune Diseases. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to evaluate national level differences in in hospital outcomes among patients with autoimmune rheumatic diseases (AIRDs) undergoing endovascular interventions for lower extremity arterial disease (LEAD). METHODS: This was a retrospective, observational cohort study using a large nationwide administrative database. Adult patients diagnosed with LEAD who underwent percutaneous endovascular interventions were analysed using the 2012 - 2020 Nationwide Inpatient Sample. Patients were stratified into four groups: systemic lupus erythematosus (SLE); rheumatoid arthritis (RA); systemic sclerosis (SSc); and a reference group without these conditions. Multivariable logistic regression was used to assess associations between AIRDs and in hospital mortality, discharge to a long term care facility (LTCF), prolonged hospital length of stay (LoS), and in hospital complications. RESULTS: Among 71 436 weighted patients, 1 739 (2.4%) had an AIRD (SLE, 0.4%; RA, 1.8%; SSc, 0.2%). Compared with the reference group, patients with RA had a statistically significantly greater risk of discharge to an LTCF (adjusted odds ratio [aOR] 1.41), prolonged LoS (aOR 1.39), and any in hospital complication (aOR 1.33), including sepsis, infections, and below knee amputation. Patients with SSc exhibited higher odds of pneumonia (aOR 2.02), respiratory failure (aOR 1.77), and minor amputations (aOR 2.89). No statistically significant differences were observed in death or total hospital costs among groups. Patients with SLE had outcomes comparable with those of the general population. CONCLUSION: Although in hospital mortality rates were similar across all groups, patients with RA were at a significantly higher risk of infective complications and major amputation during hospitalisation following endovascular intervention for LEAD. These findings underscore the need for proactive peri-operative planning and multidisciplinary care strategies tailored to the unique risks and needs of this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taitung, Taiwan; Department of Medicine, MacKay Medical University, New Taipei City, Taiwan.
- Department of Medicine, MacKay Medical University, New Taipei City, Taiwan; Division of Cardiology, Department of Internal Medicine, Taitung MacKay Memorial Hospital, Taitung, Taiwan. Electronic address: davielu.tw@yaho…
Zitieren
APA
Huang, Y. F., & Lu, M. Y. (2025). Lower Extremity Artery Endovascular Intervention Outcomes in Patients with Autoimmune Rheumatic Disease: an Analysis of the US Nationwide Inpatient Sample 2012 – 2020. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.09.052
Vancouver
Huang YF, Lu MY. Lower Extremity Artery Endovascular Intervention Outcomes in Patients with Autoimmune Rheumatic Disease: an Analysis of the US Nationwide Inpatient Sample 2012 – 2020. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.09.052
BibTeX
@article{Huang2025,
author = {Huang, Yi-Fan and Lu, Meng-Ying},
title = {Lower Extremity Artery Endovascular Intervention Outcomes in Patients with Autoimmune Rheumatic Disease: an Analysis of the US Nationwide Inpatient Sample 2012 – 2020},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2025},
doi = {10.1016/j.ejvs.2025.09.052}
}
EUVIMED